Literature DB >> 21383893

Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons.

Hongling Zhang1, Christopher Katnik, Javier Cuevas.   

Abstract

Sigma (σ) receptors have been shown to regulate multiple ion channel types in intracardiac ganglion neurons, including voltage-gated calcium and potassium channels. However, the inhibition of these channels alone cannot fully account for σ receptor-induced changes in neuronal excitability previously reported. Whole-cell patch clamp experiments were conducted under current-clamp mode in isolated intracardiac neurons from neonatal rats to assess the effects of σ receptor activation on the active membrane properties of these cells. Bath application of the pan-selective σ receptor agonist, 1,3-Di-o-tolylguanidine (DTG), and the σ-1-selective agonist, (+)-pentazocine, significantly increased the action potential latency and decreased action potential overshoot in response to depolarizing current ramps, which suggests inhibition of voltage-gated sodium channels. Whole-cell voltage clamp experiments showed that these σ agonists reversibly decrease depolarization-activated Na(+) currents in these cells at all potentials tested. The peak currents generated by membrane depolarizations were decreased in a dose dependent manner with IC(50) values for DTG and (+)-pentazocine of 32 μM and 49 μM, respectively. The σ-1 receptor-selective antagonist, BD 1063 (100 nM), inhibited DTG (30 μM) block of Na(+) currents by ∼ 50%, suggesting that the effects are mediated by activation of σ-1 receptors. DTG also shifted the steady-state inactivation curve of Na(+) channels to more negative potentials, with the membrane potential of half-activation shifting from -49 mV to -63 mV in the absence and presence of 30 μM DTG, respectively. Taken together, these results suggest that σ-1 receptor activation decreases intracardiac ganglion neuron excitability by modulating voltage-gated Na(+) channels.

Entities:  

Year:  2009        PMID: 21383893      PMCID: PMC3047267     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  34 in total

1.  Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions.

Authors:  M Novakova; V Bruderova; Z Sulova; J Kopacek; L Lacinova; R Kvetnansky; A Vasku; P Kaplan; O Krizanova; D Jurkovicova
Journal:  Gen Physiol Biophys       Date:  2007-06       Impact factor: 1.512

2.  A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats.

Authors:  Minoru Narita; Kazumi Yoshizawa; Kazue Aoki; Misa Takagi; Mayumi Miyatake; Tsutomu Suzuki
Journal:  Addict Biol       Date:  2001-09       Impact factor: 4.280

Review 3.  Intrinsic nerve plexus of mammalian heart: morphological basis of cardiac rhythmical activity?

Authors:  J Moravec; M Moravec
Journal:  Int Rev Cytol       Date:  1987

4.  Drug specificity of pharmacological dystonia.

Authors:  R R Matsumoto; M K Hemstreet; N L Lai; A Thurkauf; B R De Costa; K C Rice; S B Hellewell; W D Bowen; J M Walker
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

5.  Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine.

Authors:  K A McCracken; W D Bowen; R R Matsumoto
Journal:  Eur J Pharmacol       Date:  1999-01-15       Impact factor: 4.432

6.  [Investigations on the mechanism of the effects of ketamine (Ketanest) on circulation and respiration (author's transl)].

Authors:  U Hörnchen; G Tauberger
Journal:  Anaesthesist       Date:  1980-10       Impact factor: 1.041

7.  Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity.

Authors:  W D Bowen; B J Vilner; W Williams; C M Bertha; M E Kuehne; A E Jacobson
Journal:  Eur J Pharmacol       Date:  1995-06-06       Impact factor: 4.432

8.  Voltage-dependent sodium and calcium currents in cultured parasympathetic neurones from rat intracardiac ganglia.

Authors:  Z J Xu; D J Adams
Journal:  J Physiol       Date:  1992-10       Impact factor: 5.182

9.  Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances.

Authors:  O Soriani; H Vaudry; Y A Mei; F Roman; L Cazin
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats.

Authors:  M Novakova; C Ela; J Barg; Z Vogel; Y Hasin; Y Eilam
Journal:  Eur J Pharmacol       Date:  1995-11-03       Impact factor: 4.432

View more
  10 in total

Review 1.  PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.

Authors:  Zeinab Y Motawe; Salma S Abdelmaboud; Javier Cuevas; Jerome W Breslin
Journal:  Int J Biochem Cell Biol       Date:  2020-07-12       Impact factor: 5.085

2.  Sigma-1 receptor activation-induced glycolytic ATP production and endothelial barrier enhancement.

Authors:  Zeinab Y Motawe; Forouzandeh Farsaei; Salma S Abdelmaboud; Javier Cuevas; Jerome W Breslin
Journal:  Microcirculation       Date:  2020-04-26       Impact factor: 2.628

3.  In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics.

Authors:  Adam A Behensky; Michelle Cortes-Salva; Michael J Seminerio; Rae R Matsumoto; Jon C Antilla; Javier Cuevas
Journal:  J Pharmacol Exp Ther       Date:  2012-10-12       Impact factor: 4.030

Review 4.  The sigma-1 receptor: roles in neuronal plasticity and disease.

Authors:  Saïd Kourrich; Tsung-Ping Su; Michiko Fujimoto; Antonello Bonci
Journal:  Trends Neurosci       Date:  2012-10-23       Impact factor: 13.837

Review 5.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

6.  Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel.

Authors:  Xinying Liu; Yingmei Fu; Huan Yang; Timur Mavlyutov; Jun Li; Christopher R McCurdy; Lian-Wang Guo; Bikash R Pattnaik
Journal:  Oncotarget       Date:  2017-07-26

7.  Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels.

Authors:  Xiao-Fei Gao; Jin-Jing Yao; Yan-Lin He; Changlong Hu; Yan-Ai Mei
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

8.  Cardiac Dysfunction in the Sigma 1 Receptor Knockout Mouse Associated With Impaired Mitochondrial Dynamics and Bioenergetics.

Authors:  Chowdhury S Abdullah; Shafiul Alam; Richa Aishwarya; Sumitra Miriyala; Manikandan Panchatcharam; Mohammad Alfrad Nobel Bhuiyan; Jonette M Peretik; A Wayne Orr; Jeanne James; Hanna Osinska; Jeffrey Robbins; John N Lorenz; Md Shenuarin Bhuiyan
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

Review 9.  Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review.

Authors:  Rebecca Lewis; Jiaqi Li; Peter J McCormick; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-28

Review 10.  The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer.

Authors:  Olivier Soriani; Saïd Kourrich
Journal:  Front Neurosci       Date:  2019-11-12       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.